Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study

Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone

(2017) Matthew J. Budoff et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins

(2017) Tetsu Watanabe et al.   Journal of Cardiology

Potential benefits of eicosapentaenoic acid on atherosclerotic plaques

(2017) J.R. Nelson et al.   VASCULAR PHARMACOLOGY

Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study

(2016) Rine Nakanishi et al.   ATHEROSCLEROSIS

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies

(2016) Christie M. Ballantyne et al.   ATHEROSCLEROSIS

Effects of the Addition of Eicosapentaenoic Acid to Strong Statin Therapy on Inflammatory Cytokines and Coronary Plaque Components Assessed by Integrated Backscatter Intravascular Ultrasound

(2016) Toshiyuki Niki et al.   CIRCULATION JOURNAL

Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study

(2016) Suguru Matsumoto et al.   CLINICAL CARDIOLOGY

Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease

(2016) Tetsuji Morishita et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies

(2016) Christie M. Ballantyne et al.   Journal of Clinical Lipidology

Aged Garlic Extract Reduces Low Attenuation Plaque in Coronary Arteries of Patients with Metabolic Syndrome in a Prospective Randomized Double-Blind Study

(2016) Suguru Matsumoto et al.   JOURNAL OF NUTRITION

Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies

(2016) Harold E. Bays et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis

(2015) Kenneth M. Borow et al.   ATHEROSCLEROSIS

Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk

(2014) Rajiv Chowdhury et al.   ANNALS OF INTERNAL MEDICINE

Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia

(2014) Nobuaki Tanaka et al.   ATHEROSCLEROSIS

Residual macrovascular risk in 2013: what have we learned?

(2014) Jean-Charles Fruchart et al.   Cardiovascular Diabetology

Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies

(2013) Harold E. Bays et al.   American Journal of Cardiovascular Drugs

Effect of statin treatment on coronary plaque progression – A serial coronary CT angiography study

(2013) Irfan Zeb et al.   ATHEROSCLEROSIS

Eicosapentaenoic Acid (EPA) Reduces Cardiovascular Events: Relationship with the EPA/Arachidonic Acid Ratio

(2013) Haruo Ohnishi et al.   Journal of Atherosclerosis and Thrombosis

Relationship of Lipoproteins to Cardiovascular Events

(2013) John R. Guyton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL3+IDL])

(2013) Heidi T May et al.   Lipids in Health and Disease

Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)

(2012) Christie M. Ballantyne et al.   AMERICAN JOURNAL OF CARDIOLOGY

Comparison between integrated backscatter intravascular ultrasound and 64-slice multi-detector row computed tomography for tissue characterization and volumetric assessment of coronary plaques

(2012) Takahiko Yamaki et al.   Cardiovascular Ultrasound

Automated quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification

(2012) Mark J. Boogers et al.   EUROPEAN HEART JOURNAL

Non-obstructive low attenuation coronary plaque predicts three-year acute coronary syndrome events in patients with hypertension: Multidetector computed tomographic study

(2012) Koki Nakanishi et al.   Journal of Cardiology

THE IMPACT OF A PURE-EPA OMEGA-3 FATTY ACID ON CORONARY PLAQUE STABILIZATION; A PLAQUE COMPONENT ANALYSIS WITH 64-SLICE MULTI-DETECTOR ROW COMPUTED TOMOGRAPHY

(2012) Yoshiaki Shintani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

(2011) Harold E. Bays et al.   AMERICAN JOURNAL OF CARDIOLOGY

Assessment of progression of coronary atherosclerosis using multidetector computed tomography angiography (mdct)

(2011) Yasmin S. Hamirani et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Plaque Regression Determined by Intravascular Ultrasound Predicts Long-Term Outcomes of Patients with Acute Coronary Syndrome

(2011) Tomotaka Dohi et al.   Journal of Atherosclerosis and Thrombosis

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

(2009) Ole Faergeman et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial

(2008) Michael Miller et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY